Showing 1 - 19 results of 19 for search 'Daniel R Principe', query time: 0.05s
Refine Results
-
1
-
2
-
3
Targeting And‐1 to overcome radiation resistance in colorectal cancer by Daniel R. Principe
Published 2022-06-01
Article -
4
-
5
-
6
-
7
The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy by Daniel R. Principe, Daniel R. Principe, Patrick W. Underwood, Murray Korc, Jose G. Trevino, Hidayatullah G. Munshi, Hidayatullah G. Munshi, Ajay Rana, Ajay Rana
Published 2021-07-01
Article -
8
-
9
Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer by Daniel R. Principe, Daniel R. Principe, Lauren Chiec, Nisha A. Mohindra, Nisha A. Mohindra, Nisha A. Mohindra, Hidayatullah G. Munshi, Hidayatullah G. Munshi, Hidayatullah G. Munshi
Published 2021-06-01
Article -
10
Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer by Daniel R. Principe, Daniel R. Principe, Patrick W. Underwood, Sandeep Kumar, Kaytlin E. Timbers, Regina M. Koch, Jose G. Trevino, Hidayatullah G. Munshi, Hidayatullah G. Munshi, Ajay Rana, Ajay Rana
Published 2022-01-01
Article -
11
TGFβ Signaling in the Pancreatic Tumor Microenvironment by Daniel R. Principe, Kaytlin E. Timbers, Luke G. Atia, Regina M. Koch, Ajay Rana
Published 2021-10-01
Article -
12
-
13
-
14
Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma by Kanchan Vishnoi, Rong Ke, Navin Viswakarma, Piush Srivastava, Sandeep Kumar, Subhasis Das, Sunil Kumar Singh, Daniel R. Principe, Ajay Rana, Basabi Rana
Published 2022-07-01
Article -
15
-
16
Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies by Thao N. D. Pham, Mario A. Shields, Christina Spaulding, Daniel R. Principe, Bo Li, Patrick W. Underwood, Jose G. Trevino, David J. Bentrem, Hidayatullah G. Munshi
Published 2021-01-01
Article -
17
Inhibition of MNKs promotes macrophage immunosuppressive phenotype to limit CD8+ T cell antitumor immunity by Thao N.D. Pham, Christina Spaulding, Mario A. Shields, Anastasia E. Metropulos, Dhavan N. Shah, Mahmoud G. Khalafalla, Daniel R. Principe, David J. Bentrem, Hidayatullah G. Munshi
Published 2022-05-01
Article -
18
Genetically Induced Tumors in the Oncopig Model Invoke an Antitumor Immune Response Dominated by Cytotoxic CD8β+ T Cells and Differentiated γδ T Cells Alongside a Regulatory Respon... by Nana H. Overgaard, Nana H. Overgaard, Daniel R. Principe, Kyle M. Schachtschneider, Jeanne Toft Jakobsen, Laurie A. Rund, Paul J. Grippo, Lawrence B. Schook, Lawrence B. Schook, Gregers Jungersen
Published 2018-06-01
Article -
19
The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform by Kyle M. Schachtschneider, Regina M. Schwind, Jordan Newson, Nickolas Kinachtchouk, Mark Rizko, Nasya Mendoza-Elias, Paul Grippo, Daniel R. Principe, Alex Park, Nana H. Overgaard, Gregers Jungersen, Kelly D. Garcia, Ajay V. Maker, Laurie A. Rund, Howard Ozer, Ron C. Gaba, Lawrence B. Schook, Lawrence B. Schook
Published 2017-08-01
Article